# POLYVINYL ALCOHOL

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid4031930
Categories: beauty, cleaning, industrial, pharma
Functions: Adhesion/cohesion promoter, backing, Binder, Emulsifier, Film former, laminate, paint additive, paint additive/binder, reinforcer, Sealant (barrier), Thickening agent, Viscosity modifier
Identifier: DTXSID4031930

> POLYVINYL ALCOHOL is used as adhesion/cohesion promoter / backing. EPA CPDat observed this chemical in 761 composition records across product categories including Construction and building materials, Raw materials, Specialty occupational products. Assessed from 22 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 761 composition records across product categories including Construction and building materials, Raw materials, Specialty occupational products.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 761 composition records across product categories including Construction and building materials, Raw materials, Specialty occupational products. EPA CPDat classifies this chemical for functional uses including Film former, Viscosity modifier, Sealant (barrier).
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: IMPLANT; Potency: 0.12 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 1.4 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.4 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 1.4 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 1.4 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 1.67 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 165 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.7 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 20 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 1.4 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 420 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: AEROSOL, FOAM; Potency: 0.5 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Potency: 0.5 %w/w
- US: marketed drug occurrence — FDA NDC lists this ingredient in 10 active drug products and 10 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

_Assessed by Greenveil._